Latest market price
4.11
-0.20-4.64%
OverviewShort InterestFilings
AVIRQT41Atea Pharmaceuticals, Inc.·NASDAQ
4.11-4.64%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 06, 2026SC 13GBeneficial ownership statement (passive)
Aug 12, 202610-QQuarterly report
Aug 12, 20268-KCurrent report
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20264Statement of changes in beneficial ownership
Jun 22, 20268-KCurrent report
May 21, 20264/AStatement of changes in beneficial ownership (amended)
May 20, 20264Statement of changes in beneficial ownership
May 12, 202610-QQuarterly report
May 12, 20268-KCurrent report
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 27, 2026DEFA14AAdditional proxy soliciting materials
Apr 27, 2026DEF 14ADefinitive proxy statement
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 13, 20264Statement of changes in beneficial ownership
Mar 05, 202610-KAnnual report
Mar 05, 20268-KCurrent report
Feb 09, 2026SC 13GBeneficial ownership statement (passive)
Feb 03, 20264Statement of changes in beneficial ownership
#1 / 25 of 229
Page
▼
/ 10